This study concludes that the new H1N1 strain appeared in 2009 outbreak with high pathogenicity to human was originated as result of re-assortment (exchange of gene). Moreover, our data also suggest that the virus will remain sensitive to the pre-existing therapeutic strategies.
Background
A new H1N1 re-assortant "swine" influenza virus was recently detected in individuals from the United States who presented respiratory symptoms, and the same virus was subsequently confirmed in patients from several countries around the world . The circumstances surrounding the emergence of this pathogen, and the factors that facilitated the initial cross-species transmission, are still not fully understood. It became apparent in the early days of the outbreak that the virus can be directly transmitted between humans. Among the various efforts made to evaluate, diagnose and implement measures against the spread of virus, is the timely release of the genomic sequences from different viral isolates.
The notorious 1918 influenza pandemic-deservedly known as the "mother of all pandemics"-infected more than one quarter of the world's population and claimed an estimated 20 to 50 million human lives [3] . Two features of the influenza virus, compounded by current globalization trends, explain its ability to become a particularly worrisome zoonotic threat. One feature is the high error rate during genomic replication, which is typical of RNA viruses. The other is the segmented influenza virus genome, which facilitates re-assortment between different viral strains that infect the same cell. At a time when air travel makes it possible to reach the most remote corners of the planet in a matter of hours, any emerging or re-emerging infectious disease stops being a local issue and instead becomes a global medical and public health priority. Details of how the current influenza virus emerged, although still scarce, will enhance our knowledge about factors that enable viruses to cross the species barrier and cause disease in humans [4] . Hence, keeping above things in our mind our lab has started analyses of this new (2009) (Figure1a) . The HA gene sequences of all the three isolates shared highest homology over 95% and 93% at nucleotide and protein level was found with H1N2 strain from Indiana and H1N1 strain from Kansas, respectively ( Table 1 in supplementary material) . In contrast, the segment coding for neuraminidase gene (NA) of new human virus clustered with the swine influenza viruses from Asia and Europe from 1992-2007 outbreaks (Figure1b). However the NA genes of three isolates from 2009 outbreak showed highest homology over 94% and 92% to H1N1 strain from England and H1N1 strain from Belgium, respectively ( Table 1 in supplementary material) . Whereas H1N1 strain from Zhejiang shared at least 91% homology both at nucleotide and protein level. Thus our result suggests that the neuraminidase gene segment lies with in the Eurasian swine genetic lineage, which also corroborates with a recent report by Garten et al [7] . However all the humans isolates from H1N1 subtype recovered from 1995 to 2008 fail to clustered with these novel strains and able to make separate clustered . The HA and NA, genes from 2009 outbreak showed homology to 77% to 80% strains clustered in this group. Comparing the HA and NA genes from virus with 1918 outbreak we found that this novel virus shared at least 85% and 83% homology respectively. Previous reports suggested that mutations at amino acid H274Y and N294S made strain resistant to available drug oseltamivir [9] . Thus to investigate whether available drugs (oseltamivir, zanamivir) may be effective against the recent circulating virus, we performed the amino acids sequence alignment of NA gene with previous strains. The result revealed that no mutation was found in the conserved region of active site (data not shown), which is the potential target for the existing drugs. Thus, conserved pattern at active site of NA suggests that the virus will remain sensitive to the pre-existing therapeutic strategies.
Conclusion
This study precisely intrigue to investigate the origin of novel virus (2009) subtype H1N1 (based on two surface proteins HA & NA) prevalent in humans. Our Insilco analyses revealed that this is a reassorted virus, where swine may constitute a crucial intermediate host for transmission. Furthermore, the study also predicts the presence of conserved domains in both the surface proteins, which could be of therapeutic relevance.
